Included in Friday Links (November 10) was the title, “Would coverage for gene therapies make employer-based health insurance unaffordable?” That raises an important question: How much should employers (and employees) be required to pay for hyper-expensive therapies very few people need? A related question: should the purpose of employee health coverage be to recruit and retain workers or fund rare disease research and therapies?
Category: Health Reform
Tuesday Links
- Tyler Cowen: “Classical liberals are increasingly religious.” I don’t think this is new. I think it has been true for a long time. But I don’t know why.
- ACO failures: study of Medicare patients with depression or anxiety finds a 24 percent decline in treatment visits and no discernible improvements at twelve months after enrolling in an ACO.
- Syphilis cases in newborns is ten times what it was a decade ago. In 40% of the cases, the mother had no prenatal care.
- Infant mortality rises for the first time in 20 years.
Meditation & Mindfulness: Relief from Anxiety and Stress or a New Age Pseudoscience?
If you like to slow down and clear your mind through a structured mindfulness activity every day, feel free to do so. Just don’t think it will cure your multiple myeloma.
Monday Links
- Are apprenticeships a viable alternative to higher education? If so, why does government subsidize the latter and not the former?
- The IRA bill has already stopped the development of one cancer drug and may be delaying many more.
- Why do new drugs have such bizarre names? It’s bureaucracy gone amok.
- Study: thunderstorms cause asthma attacks.